C4PAIN ApS: Financial statements 2018
CVR: 32292402
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
C4PAIN ApS (CVR 32292402) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,764,830 and a net result of DKK 1,405,792 compared with DKK 659,611 the year before. That is an increase of 165.1% compared with the year before. Equity in the 2018 report amounted to DKK 1,558,558. The solvency ratio was 77%.
- Gross Profit
- DKK 1,764,830
- Profit/Loss
- DKK 1,405,792
- Equity
- DKK 1,558,558
- Total Assets
- DKK 2,023,346
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.8 mio. | 1.4 mio. | 1.6 mio. | - |
| 2017 | - | 666 t. | 660 t. | 812 t. | - |
| 2016 | - | -453 t. | -374 t. | 152 t. | - |
| 2015 | - | -405 t. | -235 t. | 526 t. | - |
| 2014 | - | 285 t. | 241 t. | 761 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
C4PAIN ApS has published its annual report for 2017. Gross profit came to DKK 665,845, and the net result was DKK 659,611.
About C4PAIN ApS
C4PAIN ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Arendt-Nielsen. The company is owned by BIO-MEDICAL CONSULT HOLDING ApS. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK 159,243 and a net result of DKK 185,909 compared with DKK 1,074,600 the year before. Equity in the 2025 report amounted to DKK 4,164,765.